SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-051111
Filing Date
2021-10-01
Accepted
2021-10-01 16:11:49
Documents
2
Period of Report
2021-09-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1581
2 POWER OF ATTORNEY ea148242ex24_jaspertherap.htm EX-24 6231
  Complete submission text file 0001213900-21-051111.txt   9295
Mailing Address C/O CRISPR THERAPEUTICS AG 610 MAIN STREET 7TH FLOOR CAMBRIDGE MA 02139
Business Address
Klein Lawrence Otto (Reporting) CIK: 0001762583 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 211299016

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)